- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
NTRK2 antibody, also known as Neurotrophic tyrosine kinase receptor 2 antibody, recognizes a receptor tyrosine kinase encoded by the NTRK2 gene and commonly known as TrkB. This transmembrane glycoprotein belongs to the neurotrophic receptor tyrosine kinase family and functions as a high-affinity receptor for brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NT-4). Ligand binding induces receptor dimerization and autophosphorylation, activating downstream signaling pathways including MAPK, PI3K-AKT, and PLC-gamma cascades that regulate neuronal survival, differentiation, synaptic plasticity, and axonal growth. NTRK2 is highly expressed in the central and peripheral nervous systems, particularly in cortical neurons, hippocampal neurons, and certain sensory ganglia, where it plays a critical role in development and maintenance of neuronal circuits.
Neurotrophic tyrosine kinase receptor 2 is also expressed outside the nervous system, including in thyroid, lung, and selected epithelial tissues. Aberrant activation of NTRK2 signaling has been implicated in tumorigenesis, particularly in cancers harboring NTRK gene fusions or overexpression of Trk family members. In solid tumors such as thyroid carcinoma, lung carcinoma, and certain sarcomas, NTRK2 expression may contribute to enhanced proliferation, invasion, and resistance to apoptosis. Because of its therapeutic relevance, NTRK2 has become an important molecular target in oncology research and targeted therapy development.
NTRK2 antibody (clone NTRK2/4672) targets TrkB protein expression in research applications. Detection of NTRK2 by immunohistochemistry typically demonstrates membranous and cytoplasmic staining in positive cells, consistent with its localization as a cell surface receptor that undergoes ligand-induced internalization. In neural tissues, staining is observed in neuronal cell bodies and processes, while in non-neural tissues expression patterns vary depending on differentiation status and pathologic context. Evaluation of NTRK2 expression can assist in studies of neurodevelopment, neurodegenerative disease, and tumor biology, particularly in investigations focused on neurotrophin signaling pathways.
Given its involvement in survival signaling and synaptic modulation, NTRK2 continues to be studied in psychiatric disorders, epilepsy, and neurodegenerative conditions where altered BDNF-TrkB signaling has been described. A NTRK2 antibody is suitable for detecting Neurotrophic tyrosine kinase receptor 2 expression in relevant research assays including immunohistochemistry and western blot analysis.
Optimal dilution of the NTRK2 antibody should be determined by the researcher.
A recombinant partial protein sequence (within amino acids 250-450) from the human protein was used as the immunogen for the NTRK2 antibody.
Aliquot the NTRK2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.